SEP
CLDX icon

Sound Energy Partners’s Celldex Therapeutics CLDX Stock Holding History

Sound Energy Partners’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1.58M Buy
+10,000
New +$2.83M 3.19% 12
2014
Q4 		– Sell
-3,200
Closed -$622K – 20
2014
Q3 		$622K Buy
+3,200
New +$697K 0.48% 28

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sound Energy Partners's CLDX Position: Q3 2015 in Review

Sound Energy Partners opened a new position in Celldex Therapeutics (CLDX) in Q3 2015: 10,000 shares worth $1.58M. The stake represents 3.19% of the portfolio and ranks #12 among its holdings. This is a return to the name: Sound Energy Partners previously reported a position in CLDX as recently as Q3 2014.

Sound Energy Partners first reported a position in CLDX in Q3 2014 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold CLDX as of Q3 2015.

  • Sound Energy Partners held 10,000 shares of Celldex Therapeutics worth $1.58M as of Q3 2015.
  • Celldex Therapeutics was a new Sound Energy Partners position in Q3 2015.
  • Celldex Therapeutics made up 3.19% of Sound Energy Partners's portfolio in Q3 2015, its #12 holding.
  • Sound Energy Partners first reported a position in Celldex Therapeutics in Q3 2014 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2015.

Based on Sound Energy Partners's 13F filing for Q3 2015, filed 13 Nov 2015.